Novel cerebrospinal fluid (CSF) biomarkers can potentially identify patients with one or other of the two main forms of frontotemporal lobar degeneration (FTLD), according to research conducted by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results